Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Silicone Implant Data Draw Further Criticism From Panel Chair, Public Citizen

This article was originally published in The Gray Sheet

Executive Summary

Inamed failed to supply proof of long-term safety of its silicone breast implants to FDA and the General & Plastic Surgery Devices Panel, Public Citizen contends in a Nov. 3 petition

You may also be interested in...



FDA’s Second-Guessing Of Device Applications Spurs Public Citizen Protest

Public Citizen cites FDA's vacillations over Cyberonics' VNS Therapy as the source of its concern with the device as a possible treatment for depression

Former Panel Chair Disclaims Prior Stance Against Silicone Implant Approval

The former chair of FDA's General & Plastic Surgery Devices Panel is recommending approval of silicone gel-filled breast implants, though he still takes exception with Inamed's Style 153

FDA’s Second-Guessing Of Device Applications Spurs Public Citizen Protest

Public Citizen cites FDA's vacillations over Cyberonics' VNS Therapy as the source of its concern with the device as a possible treatment for depression

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019311

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel